ILAN YARON,LALAZAR GADI,SHTEYER EYAL,BEN-YAAKOV AMI,COHEN SMADAR,ELKAYAM TSIONA
申请号：
IN3703/MUMNP/2015
公开号：
IN2015MN03703A
申请日:
2015.12.28
申请国别(地区):
IN
年份:
2016
代理人:
摘要：
The present invention relates to methods for the treatment of hepatic disorders in a subject in need thereof. More specifically, the methods of the invention are based on the administration, preferably, systemic administration, of a therapeutically effective amount of at least one biocompatible alginate biomaterial, any modification thereof and any combination thereof. The invention further provides methods for sustaining serum albumin levels, and/or reducing serum AST and ALT, in subjects suffering from hepatic disorder. Still further, the invention provides methods for reducing apoptosis and inducing cell proliferation in a damaged liver tissue of a subject suffering of hepatic disorder, using the alginate biomaterial described by the invention.
